Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen.
about
Properties, production, and applications of camelid single-domain antibody fragmentsSingle domain antibodies: promising experimental and therapeutic tools in infection and immunityEngineered single-domain antibodies with high protease resistance and thermal stabilityAffinity is an important determinant of the anti-trypanosome activity of nanobodiesJoining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesisNanobodies as novel agents for cancer therapy.Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductaseEfficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioesterMonitoring biodegradative enzymes with nanobodies raised in Camelus dromedarius with mixtures of catabolic proteins.Identification and characterization of Nanobodies targeting the EphA4 receptor.Fingerprint-like Analysis of "Nanoantibody" Selection by Phage Display Using Two Helper Phage VariantsImmunodetection of the recombinant GroEL by the Nanobody NbBruc02.Detection of biomarkers using recombinant antibodies coupled to nanostructured platformsIsolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives.Camelid nanobodies with high affinity for broad bean mottle virus: a possible promising tool to immunomodulate plant resistance against viruses.Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging.Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain.Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus.Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis.Nanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites.Characterization of Asia 1 sdAb from camels bactrianus (C. bactrianus) and conjugation with quantum dots for imaging FMDV in BHK-21 cells.Antibody technology in proteomics.Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.Nanobody; an old concept and new vehicle for immunotargeting.Antibody Fragments as Probe in Biosensor Development.Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting Nanobodies.Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting.Endogenous DKK1 and FRZB Regulate Chondrogenesis and Hypertrophy in Three-Dimensional Cultures of Human Chondrocytes and Human Mesenchymal Stem Cells.Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8.Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds.Recombinant antibody production in Arabidopsis seeds triggers an unfolded protein response.Activity modulation of microbial enzymes by llama (Lama glama) heavy-chain polyclonal antibodies during in vivo immune responses.An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen.
P2860
Q24676749-9F17897C-8D95-4262-A945-00F18583DD6DQ28248678-C4F186AA-5EA3-4A3B-9A07-EFAA59339ED9Q28478199-5B353C85-360F-453E-9B1F-598C568D8D62Q28485195-C2CAD9F7-CF57-4C3B-B0EF-8D7745375FA0Q29248081-6CDFDB2B-AAB4-429C-819B-1239FB75350BQ30778309-DCC8B572-5C88-4B29-984A-B378B75BDFC2Q33287667-66E36CD2-0010-498E-914C-86BF3154D2E5Q33412211-018F8230-C448-44D1-A501-8E6B31BE4925Q33484454-9BBE9CB1-FF7F-4ED2-9DD0-803DBA7DE402Q33789505-21340907-B1C4-42F2-B658-E69752D32E61Q33882055-C36FF0B9-50AF-44F1-8A67-E57178581241Q34287684-9BA794E8-3FB7-4FB7-A076-6EFC2B9F0614Q34340907-1EB53CF6-181D-425E-BAB9-5AA36A64954AQ34352221-FF6BC44A-1DDB-4FCD-B5CA-0738A7C0C7C6Q34878849-498549A0-8312-474C-93E1-94247B74045DQ35080243-822C5DF6-7786-448A-A41D-6FBF83E068F5Q35155775-7256C228-1364-472D-A5EA-2450605CF36DQ35554586-0E595998-3D95-498A-88AF-FFB2691F5BA7Q35674555-F88813EB-34D1-4105-A4D5-D25E2795B2D4Q35699428-D69F5C53-41E3-451A-8935-CF2976715606Q35937928-6BEAF259-9B24-4126-BB6A-B55AAFCC2D2FQ35952105-B21CB426-85AC-4479-A9AF-7A46675AE734Q36684736-7CCDAD69-1B2F-442E-AB11-8E420A012400Q36887701-1E95DF73-52C0-45C6-AE15-4D26AFE21576Q37202448-3D5E2107-E531-4796-808E-77D22F895884Q37593692-0CE0B2BB-76DB-42EB-ACE2-D054C0329EFBQ37603933-C39C01DF-63FC-4B59-B446-0970CC227F1BQ37829737-3D0FAB06-6693-4A31-87C7-1BE8C89468FFQ39016494-F0C79C63-56B8-4962-B2FC-73EEB1A08C71Q39229818-B2D8229F-775E-4A49-9846-3A61EADBE793Q39614361-F6ECD906-ACCD-4989-9B07-6D38DE037E89Q41347803-559BBFD7-1DFC-4CDA-A667-8869FDCDC78AQ41875163-29899E24-ACCD-46E7-9509-E284BFD22CEDQ41984107-E58C2B42-5034-43BC-9D41-7C2147349A96Q42571449-438E32FF-2C12-4A45-8F50-4B0DDB0DBC92Q44315654-62D8F08B-FB85-490B-967E-917E37A7B779Q46594879-86F6FC61-6904-4530-825D-37DE8D428AC1Q51397538-2426971D-E991-4351-919B-794945C2FA19Q51820924-0D0FC791-020E-4CB6-A43B-5C201B234760Q52675382-12308CE3-4C06-4131-8F21-F9CB4BBF1DF1
P2860
Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Single domain antibodies deriv ...... of prostate-specific antigen.
@ast
Single domain antibodies deriv ...... of prostate-specific antigen.
@en
type
label
Single domain antibodies deriv ...... of prostate-specific antigen.
@ast
Single domain antibodies deriv ...... of prostate-specific antigen.
@en
prefLabel
Single domain antibodies deriv ...... of prostate-specific antigen.
@ast
Single domain antibodies deriv ...... of prostate-specific antigen.
@en
P2093
P356
P1476
Single domain antibodies deriv ...... of prostate-specific antigen.
@en
P2093
Eugène Bosmans
Jörg Kinne
Katja Conrath
Ulrich Wernery
P304
51965-51972
P356
10.1074/JBC.M409292200
P407
P577
2004-09-30T00:00:00Z